NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP)

56 filings reported holding NBP - NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) as of Q3 2025.
NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) has 42 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 29.7M shares of 264M outstanding shares and own 11.23% of the company stock.
Largest 10 shareholders include JANUS HENDERSON GROUP PLC (7.99M shares), HHLR ADVISORS, LTD. (5.98M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (3.34M shares), MORGAN STANLEY (2.23M shares), Ariose Capital Management Ltd (1.7M shares), Exome Asset Management LLC (1.44M shares), Siren, L.L.C. (1.17M shares), Candriam S.C.A. (1.13M shares), Woodline Partners LP (1.05M shares), and Point72 Hong Kong Ltd (561K shares).
This table shows the top 42 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.